This additional non-dilutive EUR 7.5 million will partially fund the clinical trial of our proprietary A2A antagonist drug candidate, which is in
the exciting field of cancer immunotherapy.
Not exact matches
«The use
of the immune system through
cancer immunotherapy is a very
exciting field currently and promises to contribute significantly to elimination
of metastatic tumors,» said Fiering.
«My wife and I are proud to have affiliated with
Cancer Research Institute and enthusiastically support immunotherapy as an exciting and most promising field of cancer res
Cancer Research Institute and enthusiastically support
immunotherapy as an
exciting and most promising
field of cancer res
cancer research.